Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/2/2025

Buspirone Treatment for Generalized Anxiety Disorder (GAD)

Introduction to Buspirone Treatment

  • The American Academy of Family Physicians and the American Family Physician recommend starting buspirone at 5 mg twice daily and gradually titrating to a target dose of 20-30 mg per day in divided doses, with a maximum of 60 mg daily 1, 2

Dosage Regimens

  • A twice daily regimen of 15 mg twice daily (30 mg total) and a three times daily regimen of 10 mg three times daily (30 mg total) show similar efficacy and safety profiles 1
  • The target dose of 20-30 mg/day can be achieved through either twice daily or three times daily regimens, with no significant difference in efficacy between the two 1

Special Patient Populations

  • Elderly patients should start at lower doses and titrate more slowly 1
  • Patients with hepatic or renal impairment should use lower doses and titrate cautiously 1
  • For patients with mild to moderate hepatic or renal impairment, starting with lower doses and titrating cautiously is recommended 1

Treatment Outcomes and Monitoring

  • The full therapeutic effect of buspirone takes 2-4 weeks to manifest, and patients should be informed about this delayed onset to manage expectations 1
  • Assess therapeutic response after 2-4 weeks, as the full effect of buspirone may take up to 4 weeks to manifest 1
  • Monitor for common side effects such as dizziness, headache, nausea, nervousness, and palpitations, and adjust the treatment plan as necessary 1

Comparison to Other Treatments

  • Buspirone has demonstrated efficacy comparable to benzodiazepines for GAD 2
  • In elderly patients with GAD, buspirone shows significant anxiolytic effects, with some studies suggesting faster onset compared to SSRIs like sertraline 2
  • Buspirone is not effective for panic disorder and should not be used for this indication, highlighting the importance of accurate diagnosis 2
  • Unlike benzodiazepines, buspirone lacks sedative, muscle relaxant, and anticonvulsant properties, and there is no evidence of dependence, tolerance, or withdrawal syndrome 2

Important Considerations

  • Consider starting with a subtherapeutic "test" dose as initial adverse effects can include increased anxiety or agitation, as suggested by the American Academy of Child and Adolescent Psychiatry 2
  • Patients previously treated with benzodiazepines may perceive buspirone as less effective due to the lack of immediate sedative effects 2